Tisotumab Vedotin: First Approval
Sign Up to like & getrecommendations! Published in 2021 at "Drugs"
DOI: 10.1007/s40265-021-01633-8
Abstract: Tisotumab vedotin (Tivdak™) is an antibody-drug conjugate comprising a fully human monoclonal antibody specific for tissue factor (TF-011) conjugated to monomethyl auristatin E (MMAE) that has been engineered to target tissue factor expressing tumours. Based… read more here.
Keywords: tisotumab vedotin; vedotin; first approval; vedotin first ... See more keywords
Tisotumab vedotin; First FDA Approved Antibody-drug Conjugate for Cervical Cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520622666220421095240
Abstract: read more here.
Keywords: cancer; approved antibody; vedotin first; tisotumab vedotin ... See more keywords